Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FGSYF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,418
Award facts
- Contract value 100% obligated
- $26,418.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Stelara 45 mg/0.5 mL syringes with a ceiling value of $26,418.01. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. No set-aside designation was used for this award, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp is a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The company's portfolio encompasses a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Stelara, a specialty immunological treatment, reflects the contractor's ongoing role in supplying pharmaceutical commodities that support military medical readiness and veteran healthcare needs through the DLA supply chain.
Quick answers
Who was awarded contract SPE2DB25FGSYF?
SPE2DB25FGSYF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FGSYF worth?
The government has obligated $26,418 on SPE2DB25FGSYF.
Is contract SPE2DB25FGSYF an order under another contract?
Yes. SPE2DB25FGSYF is a delivery order under SPE2DB24D2215, an indefinite delivery contract.
Was contract SPE2DB25FGSYF competed?
The extent of competition for SPE2DB25FGSYF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award